People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Biotechnology, Hospitals and Physicians, Healthtech, Other, Other Health Care, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Intarcia Therapeutics, Inc | — | Biotechnology | Growth/Late | $1.2B | $8.4B | 2016 |
| Grand Rounds, Inc. | — | Hospitals and Physicians | Growth/Late | $904.4M | $289.9M | 2021 |
| Lyra Health, Inc. | — | Healthtech | Series D+ | $867.7M | $4.3B | 2018 |
| Fate Therapeutics Inc | — | Biotechnology | Series C | $241.3M | $2.0B | 2013 |
| Kyruus, Inc. | — | Other | Series C | $196.2M | $388.0M | 2011 |
| Castlight Health, Inc. | — | Other Health Care | Series C | $177.0M | $2.3B | 2009 |
| Smith Health, Inc. | — | Healthtech | Series C | $87.2M | $605.0M | 2022 |
| Aria Diagnostics, Inc. | — | Biotechnology | Series C | $65.2M | $2.2B | 2011 |
| Devoted Health, Inc. | — | Healthtech | Series C | $62.0M | $1.6B | 2017 |
| Accompany Health, Inc. | — | Healthtech | Series C | $56.3M | $680.1M | 2023 |
| Mythic Therapeutics, Inc. | — | Biotechnology | Series B | $53.5M | $176.2M | 2020 |
| Kelonia Therapeutics, Inc. | — | Biotechnology | Series C | $50.3M | $1.0B | 2022 |
| Stride Health, Inc. | — | Healthtech | Series B | $34.5M | $272.6M | 2017 |
| ADVANCE Medical, Ltd. | — | Other | Series B | $19.8M | $328.1M | 2013 |
| Vitae Pharmaceuticals, Inc | — | Pharmaceuticals | Series A | $15.0M | $464.6M | 2009 |
| JW Celtics Investment Corp. | — | Biotechnology | Series A | $11.0M | $100.1M | 2023 |
| Public Health Co Group, Inc. | — | Healthtech | Series A | $5.0M | $86.5M | 2021 |
| Coderyte Inc | — | Other Health Care | Seed | $2.5M | $62.0M | 2011 |
Bryan Roberts at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Bryan Roberts on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Kocher | 3 | 5 |
| Bryan E. Roberts | 2 | 6 |
| DAVID EBERSMAN | 2 | 3 |
| Kathleen Sebelius | 2 | 2 |
| Todd Park | 2 | 2 |
| Donald Trigg | 2 | 2 |
| Edward Park | 2 | 2 |
| Michael Williams | 1 | 27 |
| Robert Nelsen | 1 | 22 |
| Peter Barrett | 1 | 18 |
| Michael Lee | 1 | 15 |
| Amir Nashat | 1 | 14 |
| Josh Kopelman | 1 | 14 |
| Ed Mathers | 1 | 11 |
| David Thompson | 1 | 10 |
| William Frist | 1 | 10 |
| Dan Nova | 1 | 8 |
| Somesh Dash | 1 | 8 |
| Carl Weissman | 1 | 8 |
| Vijay Lathi | 1 | 8 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.